• This record comes from PubMed

Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control

. 2017 ; 8 () : 1733. [epub] 20171204

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection

Document type Journal Article

Persistent link   https://www.medvik.cz/link/pmid29255472

See more in PubMed

World Health Organization. Tuberculosis Fact Sheet. (2017). Available from: http://www.who.int/mediacentre/factsheets/fs104/en/

World Health Organization. Malaria Fact Sheet. (2017). Available from: http://www.who.int/mediacentre/factsheets/fs094/en/

Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature (2015) 526:207–11.10.1038/nature15535 PubMed DOI PMC

Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 371:411–23.10.1056/NEJMoa1314981 PubMed DOI PMC

Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, et al. Treatment outcomes in multidrug-resistant tuberculosis. N Engl J Med (2016) 375:1103–5.10.1056/NEJMc1603274 PubMed DOI

Lynch JB. Multidrug-resistant tuberculosis. Med Clin North Am (2013) 97:553–79.10.1016/j.mcna.2013.03.012 PubMed DOI

Cabezas-Cruz A, Mateos-Hernández L, Alberdi P, Villar M, Riveau G, Hermann E, et al. Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases. Exp Mol Med (2017) 49:e301–8.10.1038/emm.2016.164 PubMed DOI PMC

Rispens T, Derksen NI, Commins SP, Platts-Mills TA, Aalberse RC. IgE production to α-gal is accompanied by elevated levels of specific IgG1 antibodies and low amounts of IgE to blood group B. PLoS One (2013) 8:e55566.10.1371/journal.pone.0055566 PubMed DOI PMC

Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev (2015) 28:801–70.10.1128/CMR.00109-14 PubMed DOI PMC

Rao BN, Reddy VD, Sahu PS, Veerendra Kumar A, david MA, Yugandhar P, et al. The ABO blood group distribution and pulmonary tuberculosis. J Clin Diagn Res (2012) 6:943–6.10.7860/JCDR.2012.4370.2298 DOI

Lopera-Mesa TM, Doumbia S, Konaté D, Anderson JM, Doumbouya M, Keita AS, et al. Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study. Lancet Haematol (2015) 2:e140–9.10.1016/S2352-3026(15)00043-5 PubMed DOI PMC

Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Koné A, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 104:17471–6.10.1073/pnas.0705390104 PubMed DOI PMC

Goel S, Palmkvist M, Moll K, Joannin N, Lara P, Akhouri RR, et al. RIFINs are adhesins implicated in severe Plasmodium falciparum malaria. Nat Med (2015) 21:314–7.10.1038/nm.3812 PubMed DOI

Yilmaz B, Portugal S, Tran TM, Gozzelino R, Ramos S, Gomes J, et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell (2014) 159:1277–89.10.1016/j.cell.2014.10.053 PubMed DOI PMC

Galili U. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys. J Mol Evol (2015) 80:1–9.10.1007/s00239-014-9652-x PubMed DOI

Dutta A, Huang CT, Lin CY, Chen TC, Lin YC, Chang CS, et al. Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs. Sci Rep (2016) 6:32973.10.1038/srep32973 PubMed DOI PMC

Soares MP, Yilmaz B. Microbiota control of malaria transmission. Trends Parasitol (2016) 32:120–30.10.1016/j.pt.2015.11.004 PubMed DOI

Cabezas-Cruz A, de la Fuente J. Immunity to α-Gal: toward a single-antigen pan-vaccine to control major infectious diseases. ACS Cent Sci (2017) 3(11):1140–2.10.1021/acscentsci.7b00517 PubMed DOI PMC

Moura APV, Santos LCB, Brito CRN, Valencia E, Junqueira C, Filho AAP, et al. Virus-like particle display of the α-Gal carbohydrate for vaccination against Leishmania infection. ACS Cent Sci (2017) 3(9):1026–31.10.1021/acscentsci.7b00311 PubMed DOI PMC

Couto AS, Gonçalves MF, Colli W, de Lederkremer RM. The N-linked carbohydrate chain of the 85-kilodalton glycoprotein from Trypanosoma cruzi trypomastigotes contains sialyl, fucosyl and galactosyl (alpha 1-3)galactose units. Mol Biochem Parasitol (1990) 39:101–7.10.1016/0166-6851(90)90012-B PubMed DOI

Zamze SE, Ashford DA, Wooten EW, Rademacher TW, Dwek RA. Structural characterization of the asparagine-linked oligosaccharides from Trypanosoma brucei type II and type III variant surface glycoproteins. J Biol Chem (1991) 266:20244–61. PubMed

Achkar JM, Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe (2013) 13:250–62.10.1016/j.chom.2013.02.009 PubMed DOI PMC

Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev (2015) 264:167–81.10.1111/imr.12276 PubMed DOI PMC

Costello AM, Kumar A, Narayan V, Akbar MS, Ahmed S, Abou-Zeid C, et al. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans R Soc Trop Med Hyg (1992) 86:686–92.10.1016/0035-9203(92)90192-F PubMed DOI

Balu S, Reljic R, Lewis MJ, Pleass RJ, McIntosh R, van Kooten C, et al. A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol (2011) 186:3113–9.10.4049/jimmunol.1003189 PubMed DOI PMC

Plum M, Michel Y, Wallach K, Raiber T, Blank S, Bantleon FI, et al. Close-up of the immunogenic a1,3-galactose epitope as defined by a monoclonal chimeric immunoglobulin E and human serum using saturation transfer difference (STD) NMR. J Biol Chem (2011) 286:43103–11.10.1074/jbc.M111.291823 PubMed DOI PMC

Panda AK, Panda SK, Sahu AN, Tripathy R, Ravindran B, Das BK. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J (2011) 10:309.10.1186/1475-2875-10-309 PubMed DOI PMC

Amodu OK, Olaniyan SA, Adeyemo AA, Troye-Blomberg M, Olumese PE, Omotade OO. Association of the sickle cell trait and the ABO blood group with clinical severity of malaria in southwest Nigeria. Acta Trop (2012) 123:72–7.10.1016/j.actatropica.2012.03.013 PubMed DOI

Villarino NF, LeCleir GR, Denny JE, Dearth SP, Harding CL, Sloan SS, et al. Composition of the gut microbiota modulates the severity of malaria. Proc Natl Acad Sci U S A (2016) 113:2235–40.10.1073/pnas.1504887113 PubMed DOI PMC

Yooseph S, Kirkness EF, Tran TM, Harkins DM, Jones MB, Torralba MG, et al. Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infection. BMC Genomics (2015) 16:631.10.1186/s12864-015-1819-3 PubMed DOI PMC

Aakko J, Endo A, Mangani C, Maleta K, Ashorn P, Isolauri E, et al. Distinctive intestinal Lactobacillus communities in 6-month-old infants from rural Malawi and Southwestern Finland. J Pediatr Gastroenterol Nutr (2015) 61:641–8.10.1097/MPG.0000000000000878 PubMed DOI

Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun (1988) 56:1730–7. PubMed PMC

Mañez R, Blanco FJ, Díaz I, Centeno A, Lopez-Pelaez E, Hermida M, et al. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural alpha-galactosyl IgG antibodies. Xenotransplantation (2001) 8(1):15–23. PubMed

Posekany KJ, Pittman HK, Bradfield JF, Haisch CE, Verbanac KM. Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria. Infect Immun (2002) 70(11):6215–22. PubMed PMC

Denny JE, Powell WL, Schmidt NW. Local and long-distance calling: conversations between the gut microbiota and intra- and extra-gastrointestinal tract infections. Front Cell Infect Microbiol (2016) 6:41.10.3389/fcimb.2016.00041 PubMed DOI PMC

Khan N, Vidyarthi A, Nadeem S, Negi S, Nair G, Agrewala JN. Alteration in the gut microbiota provokes susceptibility to tuberculosis. Front Immunol (2016) 7:529.10.3389/fimmu.2016.00529 PubMed DOI PMC

Almeida IC, Milani SR, Gorin PA, Travassos LR. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J Immunol (1991) 146:2394–400. PubMed

Iniguez E, Schocker NS, Subramaniam K, Portillo S, Montoya AL, Al-Salem WS, et al. An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major. PLoS Negl Trop Dis (2017) 11:e0006039.10.1371/journal.pntd.0006039 PubMed DOI PMC

Cabezas-Cruz A, Valdés JJ, de la Fuente J. Control of vector-borne infectious diseases by human immunity against α-Gal. Expert Rev Vaccines (2016) 15:953–5.10.1080/14760584.2016.1181547 PubMed DOI

Kumar H, Salminen S, Verhagen H, Rowland I, Heimbach J, Bañares S, et al. Novel probiotics and prebiotics: road to the market. Curr Opin Biotechnol (2015) 32:99–103.10.1016/j.copbio.2014.11.021 PubMed DOI

Mangold A, Hercher D, Hlavin G, Liepert J, Zimmermann M, Kollmann D, et al. Anti-alpha-Gal antibody titres remain unaffected by the consumption of fermented milk containing Lactobacillus casei in healthy adults. Int J Food Sci Nutr (2012) 63:278–82.10.3109/09637486.2011.622741 PubMed DOI

Mikelsaar M, Sepp E, Štšepetova J, Songisepp E, Mändar R. Biodiversity of intestinal lactic acid bacteria in the healthy population. Adv Exp Med Biol (2016) 932:1–64.10.1007/5584_2016_3 PubMed DOI

van Hylckama Vlieg JE, Rademaker JL, Bachmann H, Molenaar D, Kelly WJ, Siezen RJ. Natural diversity and adaptive responses of Lactococcus lactis. Curr Opin Biotechnol (2006) 17:183–90.10.1016/j.copbio.2006.02.007 PubMed DOI

Bottacini F, Ventura M, van Sinderen D, O’Connell Motherway M. Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Fact (2014) 13(Suppl 1):S4.10.1186/1475-2859-13-S1-S4 PubMed DOI PMC

Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK. Synthetic toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One (2012) 7:e30839.10.1371/journal.pone.0030839 PubMed DOI PMC

Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, et al. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J Gastroenterol (2016) 22:5505–11.10.3748/wjg.v22.i24.5505 PubMed DOI PMC

Chen C, Liu B, Xu Y, Utkina N, Zhou D, Danilov L, et al. Biochemical characterization of the novel α-1,3-galactosyltransferase WclR from Escherichia coli O3. Carbohydr Res (2016) 430:36–43.10.1016/j.carres.2016.04.012 PubMed DOI

Han W, Cai L, Wu B, Li L, Xiao Z, Cheng J, et al. The wciN gene encodes an α-1,3-galactosyltransferase involved in the biosynthesis of the capsule repeating unit of Streptococcus pneumoniae serotype 6B. Biochemistry (2012) 51:5804–10.10.1021/bi300640b PubMed DOI PMC

Find record

Citation metrics

Archiving options